Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine

Combinations of doxorubicin and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 10 long-term stabilizations were observed. No unexpected toxicity occurred. © 2000 Cancer Research Campaign

Detalles Bibliográficos
Autores principales: Nocera, M, Baudin, E, Pellegriti, G, Cailleux, A F, Mechelany-Corone, C, Schlumberger, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363532/
https://www.ncbi.nlm.nih.gov/pubmed/10952773
http://dx.doi.org/10.1054/bjoc.2000.1314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363532/
https://www.ncbi.nlm.nih.gov/pubmed/10952773
http://dx.doi.org/10.1054/bjoc.2000.1314

Ejemplares similares